Azaindole inhibitors of Aurora kinases

Details Azaindole inhibitors of Aurora kinases Azaindole inhibitors of Aurora kinases

2008-08-04

2009-10-20

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S356100

Reexamination Certificate

active

07605266

ABSTRACT:
The present invention relates to a compound represented by Formula (I):and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.

REFERENCES:
patent: 6770643 (2004-08-01), Cox et al.
patent: 7282588 (2007-10-01), Dhanak et al.
patent: 7419988 (2008-09-01), Dhanak et al.
patent: 2006/0211678 (2006-09-01), Ahmed et al.
patent: WO2007/076423 (2007-07-01), None
Ikezoe et al. Cancer Letters 262, 1-9, 2008.
Li et al. Clinical Cancer Research, 9, p. 991-997, 2003.
Yang et al. Blood, 110 (6), 2034-2040, 2007.
Tchatchou et al. Cancer Letter 247, 266-272, 2007.
Ogino et al. Neoplasia, 11 (5), 418-425, 2009.
Berger et al. Experimental and Molecular Therapeutics 23: Kinases and Oncogenesis, Abstract #3017, 2006.

Affiliated with

Also associated with

Rating

Azaindole inhibitors of Aurora kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azaindole inhibitors of Aurora kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindole inhibitors of Aurora kinases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4143797